UBS Group’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-4,056
| Closed | -$1.83K | – | 9037 |
|
|
2024
Q1 | $1.83K | Sell |
4,056
-61,668
| -94% | -$27.7K | ﹤0.01% | 6870 |
|
|
2023
Q4 | $48.6K | Buy |
+65,724
| New | +$48.6K | ﹤0.01% | 5344 |
|
|
2023
Q3 | – | Sell |
-68
| Closed | -$127 | – | 8857 |
|
|
2023
Q2 | $127 | Sell |
68
-118
| -63% | -$220 | ﹤0.01% | 7385 |
|
|
2023
Q1 | $689 | Buy |
+186
| New | +$689 | ﹤0.01% | 7825 |
|
|
2022
Q3 | – | Sell |
-123
| Closed | -$3K | – | 9941 |
|
|
2022
Q2 | $3K | Buy |
+123
| New | +$3K | ﹤0.01% | 8361 |
|
|
2022
Q1 | – | Sell |
-372
| Closed | -$21K | – | 9809 |
|
|
2021
Q4 | $21K | Buy |
372
+113
| +44% | +$6.38K | ﹤0.01% | 6688 |
|
|
2021
Q3 | $19K | Buy |
259
+253
| +4,217% | +$18.6K | ﹤0.01% | 6096 |
|
|
2021
Q2 | $1K | Sell |
6
-140
| -96% | -$23.3K | ﹤0.01% | 8104 |
|
|
2021
Q1 | $22K | Buy |
146
+5
| +4% | +$753 | ﹤0.01% | 6287 |
|
|
2020
Q4 | $19K | Buy |
141
+68
| +93% | +$9.16K | ﹤0.01% | 5980 |
|
|
2020
Q3 | $11K | Sell |
73
-209
| -74% | -$31.5K | ﹤0.01% | 5919 |
|
|
2020
Q2 | $49K | Buy |
282
+275
| +3,929% | +$47.8K | ﹤0.01% | 5043 |
|
|
2020
Q1 | $1K | Sell |
7
-10
| -59% | -$1.43K | ﹤0.01% | 6897 |
|
|
2019
Q4 | $2K | Sell |
17
-170
| -91% | -$20K | ﹤0.01% | 6790 |
|
|
2019
Q3 | $19K | Buy |
187
+127
| +212% | +$12.9K | ﹤0.01% | 5811 |
|
|
2019
Q2 | $4K | Buy |
60
+50
| +500% | +$3.33K | ﹤0.01% | 6593 |
|
|
2019
Q1 | $0 | Sell |
10
-218
| -96% | – | ﹤0.01% | 7200 |
|
|
2018
Q4 | $8K | Buy |
228
+143
| +168% | +$5.02K | ﹤0.01% | 6439 |
|
|
2018
Q3 | $7K | Buy |
85
+34
| +67% | +$2.8K | ﹤0.01% | 6429 |
|
|
2018
Q2 | $4K | Sell |
51
-69
| -58% | -$5.41K | ﹤0.01% | 6647 |
|
|
2018
Q1 | $11K | Buy |
120
+110
| +1,100% | +$10.1K | ﹤0.01% | 5936 |
|
|
2017
Q4 | $7K | Sell |
10
-65
| -87% | -$45.5K | ﹤0.01% | 6275 |
|
|
2017
Q3 | $22K | Buy |
75
+65
| +650% | +$19.1K | ﹤0.01% | 5485 |
|
|
2017
Q2 | $2K | Sell |
10
-20
| -67% | -$4K | ﹤0.01% | 6455 |
|
|
2017
Q1 | $10K | Sell |
30
-12
| -29% | -$4K | ﹤0.01% | 5700 |
|
|
2016
Q4 | $25K | Hold |
42
| – | – | ﹤0.01% | 5443 |
|
|
2016
Q3 | $48K | Buy |
42
+5
| +14% | +$5.71K | ﹤0.01% | 4692 |
|
|
2016
Q2 | $40K | Sell |
37
-5
| -12% | -$5.41K | ﹤0.01% | 4832 |
|
|
2016
Q1 | $54K | Sell |
42
-25
| -37% | -$32.1K | ﹤0.01% | 4656 |
|
|
2015
Q4 | $165K | Sell |
67
-5
| -7% | -$12.3K | ﹤0.01% | 3894 |
|
|
2015
Q3 | $80K | Sell |
72
-9
| -11% | -$10K | ﹤0.01% | 4359 |
|
|
2015
Q2 | $82K | Sell |
81
-17
| -17% | -$17.2K | ﹤0.01% | 4438 |
|
|
2015
Q1 | $100K | Buy |
98
+11
| +13% | +$11.2K | ﹤0.01% | 4192 |
|
|
2014
Q4 | $290K | Buy |
+87
| New | +$290K | ﹤0.01% | 3528 |
|